Mylan Financial Statements
Mylan Financial Information
| Company Type | Public |
|---|---|
| Fiscal Year-End | December |
| Annual Report | Company Web Site |
| Investor Relations | Company Web Site |
Mylan Income Statement
| 2007+ | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,611.8 | 1,611.8 | 1,257.2 |
| Gross Profit ($ mil.) | 843.7 | 843.7 | 627.6 |
| Operating Income ($ mil.) | 427.5 | 427.5 | 287.4 |
| Total Net Income ($ mil.) | 217.3 | 217.3 | 184.5 |
| Diluted EPS (Net Income) | 0.99 | 0.99 | 0.79 |
- # Fiscal year-end changed since last report from March to December
Mylan Quarterly Statements
| Quarter Ending Jun 08 | Quarter Ending Mar 08 | Quarter Ending Dec 07 | |
|---|---|---|---|
| Revenue ($ mil.) | 1,203.1 | 1,074.5 | 42.1 |
| Gross Profit ($ mil.) | 414.2 | 350.2 | 28.6 |
| Operating Income ($ mil.) | 74.0 | (371.5) | (40.5) |
| Total Net Income ($ mil.) | 26.4 | (409.2) | (92.0) |
| Diluted EPS (Net Income) | (0.03) | (1.46) | (0.24) |
Mylan Stock Quote & Chart
| 12/02/08 12:38:55 EST •
NYSE •
9.15
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
Mylan Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.68 | 2.21 | 1.01 |
| Price/Earnings Ratio | -- | 10.04 | 10.65 |
| Price/Book Ratio | 0.61 | 1.74 | 0.97 |
| Price/Cash Flow Ratio | 4.97 | 8.70 | 6.25 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed Mylan Financial Ratios
Mylan Competitive Intelligence
| Sandoz International GmbH | Teva Pharmaceuticals | Watson Pharmaceuticals | |
|---|---|---|---|
| Annual Sales ($ mil.) | 3,045.0 | 9,408.0 | 2,496.6 |
| Employees | 13,397 | -- | 5,640 |
| Market Cap ($ mil.) | -- | -- | 2,429.7 |
Competitive Landscape





